Eton Pharmaceuticals Appoints New CFO

Ticker: ETON · Form: 8-K · Filed: Apr 16, 2026 · CIK: 0001710340

Eton Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyEton Pharmaceuticals, Inc. (ETON)
Form Type8-K
Filed DateApr 16, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, cfo, personnel-change

TL;DR

Eton Pharma got a new CFO, filing released 4/16/26.

AI Summary

Eton Pharmaceuticals, Inc. announced on April 16, 2026, the appointment of a new Chief Financial Officer (CFO). The press release, filed as Exhibit 99.1, details this executive change.

Why It Matters

Changes in key executive positions like CFO can signal shifts in financial strategy or operational focus for a company.

Risk Assessment

Risk Level: low — This filing is a routine announcement of an executive appointment and does not contain significant financial or operational disclosures that would inherently increase risk.

Key Players & Entities

  • Eton Pharmaceuticals, Inc. (company) — The company making the filing.
  • Chief Financial Officer (person) — The position being filled.
  • April 16, 2026 (date) — The date of the filing and announcement.

FAQ

Who has been appointed as the new Chief Financial Officer?

The filing does not explicitly name the individual appointed as the new CFO, but it announces the appointment through Exhibit 99.1.

What is the effective date of the CFO appointment?

The filing date is April 16, 2026, and the press release relates to the CFO appointment, implying the appointment is effective around this date.

What other items are included in this 8-K filing?

This 8-K filing includes Item 5.02 (Departure/Election of Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), with Exhibit 99.1 being a press release about the CFO appointment.

Where is Eton Pharmaceuticals, Inc. located?

Eton Pharmaceuticals, Inc. has its mailing and business address at 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278.

What is the CIK number for Eton Pharmaceuticals, Inc.?

The CIK number for Eton Pharmaceuticals, Inc. is 0001710340.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2026 by Chief Financial Officer regarding Eton Pharmaceuticals, Inc. (ETON).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.